- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06829095
Personalized Nutrition Counseling and Nutritional Status of Esophageal Cancer and HNSCC Patients Undergoing CCRT
February 14, 2025 updated by: Hsuan-Chih Kuo, Chang Gung Memorial Hospital
Personalized Nutrition Counseling to Improve the Nutritional Status of Esophageal Cancer or Head and Neck Cancer Patients Undergoing Concurrent Chemoradiotherapy
The purpose of the study is to improve the nutritional status of esophageal cancer patients undergoing concurrent chemoradiotherapy by the personalized nutrition counseling.Dietitians consult with participants which invited to be the experimental group and follow up weekly through communication software (Line) or telephone remote methods.
Dietitians provide the dietary advice base on the guidance of the cancer diet principles, and give on assessment and diet adjustments.
At the same time, Under the same condition of nutritional supplements in both the experimental group and the control group, the investigators explore the changes in the quality of life and nutritional status of the subjects by evaluating with the nutrition Index (PG-SGA) and quality of life (EORTC QLQ-C30 questionnaire Taiwan version) questionnaire evaluation and recode the basic physical data, including body weight, grip strength, body muscle fat composition.
Therefore, investigators conducted this study to appoint dietitian to arrange personalized nutrition consultation for esophageal cancer patients to improve the nutritional status of these patients.
Study Overview
Status
Recruiting
Conditions
Detailed Description
Approximately 60-85% of esophageal cancer patients present with malnutrition at diagnosis (1).
Malnutrition, defined as body weight loss of more than 10% over the previous 6 months is associated with treatment response and survival (2).
Around 38% of esophageal cancer patients are managed with curative intent in the form of neoadjuvant chemotherapy or chemoradiotherapy followed by esophagectomy (3).
Individuals are at increased risk of malnutrition arising from disease related symptoms and neoadjuvant treatment.
Nutritional status serves as an important risk factor for major complications after operation (4) Therefore, assessment of nutritional status should be undertaken for all esophageal cancer patients, especially for those who are planned to receive esophagectomy (5).
The nutritional assessment includes hand grip for muscle mass (6), body composition for lean body mass and sarcopenia (7), body mass index- body weight loss grade (BMI-BWL grade) for generalized nutrition status (8).
These tools are needed to be integrated and individualized to esophageal cancer patients to improve outcome.
Therefore, investigators conducted this trial to appoint dietitian to arrange personalized nutrition consultation for esophageal cancer patients to improve the nutritional status of these patients.
Study Type
Observational
Enrollment (Estimated)
90
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Chia-Hsun Hsieh
- Phone Number: 0975366137
- Email: wisdom5000@gmail.com
Study Contact Backup
- Name: Hsuan-Chih Kuo
- Phone Number: 0975360665
- Email: hsuanchihkuo@gmail.com
Study Locations
-
-
-
New Taipei City, Taiwan, 236
- Recruiting
- Chang Gung Memorial Hospital
-
Contact:
- Hsuan-Chih Kuo
- Phone Number: 0975366137
- Email: wisdom2000@gmail.com
-
Contact:
- Chia-Hsun Hsieh
- Phone Number: 0975360665
- Email: hsuanchihkuo@gmail.com
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Sampling Method
Probability Sample
Study Population
Esophageal cancer or head and neck cancer patients undergoing concurrent chemoradiotherapy
Description
Inclusion Criteria:
- pathologically and CT confirmed esophageal cancer or head and neck cancer
- CCRT therapy
- ECOG performance status grade≦2
- agree to participate the trial
- over 18 years
- no pregnant
Exclusion Criteria:
- have two or more cancers
- gastrointestinal tract cannot function
- NYHA class 4
- abnormal liver and kidney function
- Abnormal bone marrow hematopoiesis
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
|---|
|
control
Under the same condition of nutritional supplements in both the experimental group and the control group,the investigators explore the changes in the quality of life and nutritional status of the subjects by evaluating with the nutrition Index (PG-SGA) and quality of life (EORTC QLQ-C30 questionnaire Taiwan version) questionnaire evaluation and recode the basic physical data, including body weight, grip strength, body muscle fat composition.
|
|
experimental
Dietitians consult with participants which invited to be the experimental group and follow up weekly through communication software (Line) or telephone remote methods.
Dietitians provide the dietary advice base on the guidance of the cancer diet principles, and give on assessment and diet adjustments.Under the same condition of nutritional supplements in both the experimental group and the control group,the investigators explore the changes in the quality of life and nutritional status of the subjects by evaluating with the nutrition Index (PG-SGA) and quality of life (EORTC QLQ-C30 questionnaire Taiwan version) questionnaire evaluation and recode the basic physical data, including body weight, grip strength, body muscle fat composition.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
BMI in kg/m^2-W1
Time Frame: baseline
|
Document of participant's BMI and evaluating the effectiveness of nutritionist health education nutritional status
|
baseline
|
|
BMI in kg/m^2-W2
Time Frame: 2nd week
|
Document of participant's BMI and evaluating the effectiveness of nutritionist health education nutritional status
|
2nd week
|
|
BMI in kg/m^2-W3
Time Frame: 3rd week
|
Document of participant's BMI and evaluating the effectiveness of nutritionist health education nutritional status
|
3rd week
|
|
BMI in kg/m^2-W4
Time Frame: 4th week
|
Document of participant's BMI and evaluating the effectiveness of nutritionist health education nutritional status
|
4th week
|
|
BMI in kg/m^2-W5
Time Frame: 5th week
|
Document of participant's BMI and evaluating the effectiveness of nutritionist health education nutritional status
|
5th week
|
|
BMI in kg/m^2-W6
Time Frame: 6th week
|
Document of participant's BMI and evaluating the effectiveness of nutritionist health education nutritional status
|
6th week
|
|
BMI in kg/m^2-W12
Time Frame: 12th week
|
Document of participant's BMI and evaluating the effectiveness of nutritionist health education nutritional status
|
12th week
|
|
BMI in kg/m^2-W18
Time Frame: 18th week
|
Document of participant's BMI and evaluating the effectiveness of nutritionist health education nutritional status
|
18th week
|
|
BMI in kg/m^2-W30
Time Frame: 30th week
|
Document of participant's BMI and evaluating the effectiveness of nutritionist health education nutritional status
|
30th week
|
|
hand grip in kg-W1
Time Frame: baseline
|
Document of participant's hand grip and evaluating the effectiveness of nutritionist health education nutritional status
|
baseline
|
|
hand grip in kg-W2
Time Frame: 2nd week
|
Document of participant's hand grip and evaluating the effectiveness of nutritionist health education nutritional status
|
2nd week
|
|
hand grip in kg-W3
Time Frame: 3rd week
|
Document of participant's hand grip and evaluating the effectiveness of nutritionist health education nutritional status
|
3rd week
|
|
hand grip in kg-W4
Time Frame: 4th week
|
Document of participant's hand grip and evaluating the effectiveness of nutritionist health education nutritional status
|
4th week
|
|
hand grip in kg-W5
Time Frame: 5th week
|
Document of participant's hand grip and evaluating the effectiveness of nutritionist health education nutritional status
|
5th week
|
|
hand grip in kg-W6
Time Frame: 6th week
|
Document of participant's hand grip and evaluating the effectiveness of nutritionist health education nutritional status
|
6th week
|
|
hand grip in kg-W12
Time Frame: 12th week
|
Document of participant's hand grip and evaluating the effectiveness of nutritionist health education nutritional status
|
12th week
|
|
hand grip in kg-W18
Time Frame: 18th week
|
Document of participant's hand grip and evaluating the effectiveness of nutritionist health education nutritional status
|
18th week
|
|
hand grip in kg-W30
Time Frame: 30th week
|
Document of participant's hand grip and evaluating the effectiveness of nutritionist health education nutritional status
|
30th week
|
|
body fat in kg-W1
Time Frame: baseline
|
Document of participant's body fat and evaluating the effectiveness of nutritionist health education nutritional status
|
baseline
|
|
body fat in kg-W2
Time Frame: 2nd week
|
Document of participant's hand grip and evaluating the effectiveness of nutritionist health education nutritional status
|
2nd week
|
|
body fat in kg-W3
Time Frame: 3rd week
|
Document of participant's body fat and evaluating the effectiveness of nutritionist health education nutritional status
|
3rd week
|
|
body fat in kg-W4
Time Frame: 4th week
|
Document of participant's body fat and evaluating the effectiveness of nutritionist health education nutritional status
|
4th week
|
|
body fat in kg-W5
Time Frame: 5th week
|
Document of participant's body fat and evaluating the effectiveness of nutritionist health education nutritional status
|
5th week
|
|
body fat in kg-W6
Time Frame: 6th week
|
Document of participant's body fat and evaluating the effectiveness of nutritionist health education nutritional status
|
6th week
|
|
body fat in kg-W12
Time Frame: 12th week
|
Document of participant's body fat and evaluating the effectiveness of nutritionist health education nutritional status
|
12th week
|
|
body fat in kg-W18
Time Frame: 18th week
|
Document of participant's body fat and evaluating the effectiveness of nutritionist health education nutritional status
|
18th week
|
|
body fat in kg-W30
Time Frame: 30th week
|
Document of participant's body fat and evaluating the effectiveness of nutritionist health education nutritional status
|
30th week
|
|
muscle weight in kg-W1
Time Frame: baseline
|
Document of participant's muscle weight and evaluating the effectiveness of nutritionist health education nutritional status
|
baseline
|
|
muscle weight in kg-W2
Time Frame: 2nd week
|
Document of participant's muscle weight and evaluating the effectiveness of nutritionist health education nutritional status
|
2nd week
|
|
muscle weight in kg-W3
Time Frame: 3rd week
|
Document of participant's muscle weight and evaluating the effectiveness of nutritionist health education nutritional status
|
3rd week
|
|
muscle weight in kg-W4
Time Frame: 4th week
|
Document of participant's muscle weight and evaluating the effectiveness of nutritionist health education nutritional status
|
4th week
|
|
muscle weight in kg-W5
Time Frame: 5th week
|
Document of participant's muscle weight and evaluating the effectiveness of nutritionist health education nutritional status
|
5th week
|
|
muscle weight in kg-W6
Time Frame: 6th week
|
Document of participant's muscle weight and evaluating the effectiveness of nutritionist health education nutritional status
|
6th week
|
|
muscle weight in kg-W12
Time Frame: 12th week
|
Document of participant's muscle weight and evaluating the effectiveness of nutritionist health education nutritional status
|
12th week
|
|
muscle weight in kg-W18
Time Frame: 18th week
|
Document of participant's muscle weight and evaluating the effectiveness of nutritionist health education nutritional status
|
18th week
|
|
muscle weight in kg-W30
Time Frame: 30th week
|
Document of participant's muscle weight and evaluating the effectiveness of nutritionist health education nutritional status
|
30th week
|
|
CTC cell number counting in number-W1
Time Frame: baseline
|
Document of participant's CTC cell number counting and evaluating the effectiveness of nutritionist health education nutritional status
|
baseline
|
|
CTC cell number counting in number-W6
Time Frame: 6th week
|
Document of participant's CTC cell number counting and evaluating the effectiveness of nutritionist health education nutritional status
|
6th week
|
|
CTC cell number counting in number-W18
Time Frame: 18th week
|
Document of participant's CTC cell number counting and evaluating the effectiveness of nutritionist health education nutritional status
|
18th week
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Abridged Patient-Generated Subjective Global Assessment, aPG-SGA Questionnaire W1
Time Frame: baseline
|
nutrition consultation and do the SGA questionnaire(the minimum value is 1 and the maximum value is 36.
The higher scores mean a worse outcome) for recoding and improving the nutritional status of participants.
|
baseline
|
|
Abridged Patient-Generated Subjective Global Assessment, aPG-SGA Questionnaire W3
Time Frame: 3th week
|
nutrition consultation and do the SGA questionnaire(the minimum value is 1 and the maximum value is 36.
The higher scores mean a worse outcome) for recoding and improving the nutritional status of participants.
|
3th week
|
|
Abridged Patient-Generated Subjective Global Assessment, aPG-SGA Questionnaire W6
Time Frame: 6th week
|
nutrition consultation and do the SGA questionnaire(the minimum value is 1 and the maximum value is 36.
The higher scores mean a worse outcome) for recoding and improving the nutritional status of participants.
|
6th week
|
|
aPG SGA Questionnaire W18
Time Frame: 18th week
|
nutrition consultation and do the SGA questionnaire(the minimum value is 1 and the maximum value is 36.
The higher scores mean a worse outcome) for recoding and improving the nutritional status of participants.
|
18th week
|
|
SGA-Questionnaire W30
Time Frame: 30th week
|
nutrition consultation and do the SGA questionnaire(the minimum value is 1 and the maximum value is 36.
The higher scores mean a worse outcome) for recoding and improving the nutritional status of participants.
|
30th week
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Director: Hsuan-Chih Kuo, Division of Oncology, Chang Gung Memorial Hospital
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
August 22, 2023
Primary Completion (Estimated)
June 30, 2025
Study Completion (Estimated)
June 30, 2025
Study Registration Dates
First Submitted
November 10, 2023
First Submitted That Met QC Criteria
February 14, 2025
First Posted (Actual)
March 25, 2025
Study Record Updates
Last Update Posted (Actual)
March 25, 2025
Last Update Submitted That Met QC Criteria
February 14, 2025
Last Verified
February 1, 2025
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 202300755B0
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Esophageal Cancer
-
OHSU Knight Cancer InstituteOregon Health and Science UniversityWithdrawnStage IIB Esophageal Cancer AJCC v7 | Stage III Esophageal Cancer AJCC v7 | Stage IIIA Esophageal Cancer AJCC v7 | Stage IIIB Esophageal Cancer AJCC v7 | Stage IIIC Esophageal Cancer AJCC v7
-
National Cancer Institute (NCI)NRG OncologyCompletedEsophageal Adenocarcinoma | Gastroesophageal Junction Adenocarcinoma | Stage IIA Esophageal Cancer AJCC v7 | Stage IIB Esophageal Cancer AJCC v7 | Stage IIIA Esophageal Cancer AJCC v7 | Stage IIIB Esophageal Cancer AJCC v7 | Stage IB Esophageal Cancer AJCC v7United States
-
Essen BiotechRecruitingStomach Cancer | Esophageal Cancer | Stomach Cancer, Adenocarcinoma | Stomach Cancer Recurrent | Esophageal Cancer Metastatic to Bone | Esophageal Cancer Metastatic to Lung | Esophageal Cancer Metastatic to LiverChina
-
AIO-Studien-gGmbHBristol-Myers SquibbCompletedEsophageal Cancer | Gastrooesophageal Cancer | Oesophageal Cancer | GastroEsophageal Cancer | Esophageal Cancers NOS | Oesophageal Cancer Metastatic | Esophageal Cancer Metastatic | Oesophageal Cancer NosGermany
-
University of Wisconsin, MadisonCompletedResectable Esophageal Cancer | GastroEsophageal CancerUnited States
-
Tianjin Medical University Cancer Institute and...Sun Yat-sen University; Cancer Institute and Hospital, Chinese Academy of Medical... and other collaboratorsNot yet recruitingStage III Esophageal Cancer | Stage II Esophageal Cancer
-
Tianjin Medical University Cancer Institute and...UnknownStage III Esophageal Cancer | Stage II Esophageal CancerChina
-
Cancer Institute and Hospital, Chinese Academy...Tianjin Medical University Cancer Institute and Hospital; Sichuan Cancer Hospital...UnknownEsophageal Neoplasm | Esophageal Cancer TNM Staging Primary Tumor (T) T3 | Esophageal Cancer TNM Staging Primary Tumor (T) T2 | Esophageal Cancer TNM Staging Regional Lymph Nodes (N) N0 | Esophageal Cancer TNM Staging Distal Metastasis (M) M0China
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedGastroesophageal Junction Adenocarcinoma | Stage IIA Esophageal Cancer AJCC v7 | Stage IIB Esophageal Cancer AJCC v7 | Stage IIIA Esophageal Cancer AJCC v7 | Stage IIIB Esophageal Cancer AJCC v7 | Stage IIIC Esophageal Cancer AJCC v7 | Malignant Neoplasm of the Cervical Esophagus | Malignant Neoplasm...United States
-
Academisch Medisch Centrum - Universiteit van Amsterdam...UMC UtrechtCompletedEsophageal Cancer, Stage II | Esophageal Cancer Stage IIINetherlands